Professor Bobby Reiner, MS, PhD, provides an update of the IHME COVID-19 model.
Low levels of government and social trust, as well as higher levels of government corruption, are strongly correlated to higher COVID-19 infection rates around the world, according to a new peer-reviewed study published today in The Lancet.
We sought to understand the conditions associated with cross-country variation in COVID-19 infection and fatality rates, in order to guide investment in more effective preparedness and response for future pandemics.
This session, presented by Awoke Misganaw Temesgen, is part of the Health Metrics Sciences lecture series.
New estimates reveal that at least 1.27 million deaths per year are directly attributable to antimicrobial resistance (AMR), requiring urgent action from policymakers and health communities to avoid further preventable deaths.
Antimicrobial resistance (AMR) poses a major threat to human health around the world. Previous publications have estimated the effect of AMR on incidence, deaths, hospital length of stay, and health-care costs for specific pathogen–drug combinations in select locations. To our knowledge, this study presents the most comprehensive estimates of AMR burden to date.
More than 1.2 million people – and potentially millions more – died in 2019 as a direct result of antibiotic-resistant bacterial infections, according to the most comprehensive estimate to date of the global impact of antimicrobial resistance (AMR).
Using data from the 2019 Global Burden of Diseases, Injuries and Risk Factors Study (GBD 2019), we evaluated national and provincial health trends and progress towards important Sustainable Development Goal targets from 1990 to 2019.
We aimed to measure the global, regional, and national prevalence, disability-adjusted life-years (DALYS), years lived with disability (YLDs), and years of life lost (YLLs) for mental disorders from 1990 to 2019.
This study aimed to improve on previous forecasts of dementia prevalence by producing country-level estimates and incorporating information on selected risk factors.
The number of adults (aged 40 years and older) living with dementia worldwide is expected to nearly triple, from an estimated 57 million in 2019 to 153 million in 2050, due primarily to population growth and population ageing.
We assess the impact of SMI on the staffing and availability of equipment and supplies for delivery care, the proportion of institutional deliveries, and the proportion of women who choose a facility other than the one closest to their locality of residence for delivery.
A new study published by IHME highlighted global disparities in cancer burden as new cases rise to 23 million.
This study aimed to estimate cancer burden and trends globally for 204 countries and territories and by Sociodemographic Index (SDI) quintiles from 2010 to 2019.
We conducted a meta-regression analysis of published cost-effectiveness analyses of human papillomavirus (HPV) vaccination to quantify the effects of factors at the country, intervention, and method-level, and predict incremental cost-effectiveness ratios (ICERs) for HPV vaccination in 195 countries.
Published by the Health Effects Institute, Research Report 210 presents a study conducted by Dr. Erin McDuffie and Dr. Randall Martin of Washington University in St. Louis, Missouri, Dr. Michael Brauer at The University of British Columbia in Canada and the Institute for Health Metrics and Evaluation (IHME), and colleagues.
Join us in celebrating the accomplishments of 2021 Roux Prize winner Dr. Zulfiqar Bhutta.
Dr. Ashish Jha, Dean of Brown University School of Public Health and Christopher Murray, Professor & Chair, Health Metrics Sciences and Director, Institute for Health Metrics and Evaluation at the University of Washington discussed their respective roles in addressing COVID-19 and their observations and hopes for the future.
Join us in celebrating the accomplishments of 2021 Roux Prize winner Dr. Zulfiqar Bhutta and congratulating the winner of the GBD Emerging Researcher Award Dr. Leopold Aminde.
We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, with a focus on the outcome of disability-adjusted life-years (DALYs), to inform global cancer control measures in adolescents and young adults.
Maria de Fatima Marinho de Souza presents on verbal autopsy in Brazil as part of the Health Metrics Sciences lecture series.
Our objective was to assess the impact of the Salud Mesoamérica Initiative on neonatal asphyxia care in health centers and hospitals in the region.
The aim of this analysis from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) is to investigate the disease burden of stroke and its risk factors at national and provincial levels in China from 1990 to 2019.
We aimed to investigate the burden of falls among older people at the national and subnational level in mainland China, and explore the trends from 1990 to 2019, using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019.
As part of the Global Burden of Disease study, we estimated the all-age population who are highly susceptible to tuberculosis through household exposure.